CARMAT achieves first commercial implant of artificial heart in Italy
The company received CE marking for its artificial heart as a bridge to transplant in December last year
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Jul 21
The company received CE marking for its artificial heart as a bridge to transplant in December last year
19 Jul 21
The first patient was implanted in Italy, at Città di Lecce Hospital with a Bicarbon aortic mechanical valve
16 Jul 21
The combined entity will operate as HeartFlow Group with an estimated $400m in cash
16 Jul 21
The company has also acquired peripheral thrombectomy company Truvic Medical, in a stock-for-stock transaction
15 Jul 21
The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs
09 Jul 21
The company will enroll up to 50 patients in the trial at up to 15 centres in the…
07 Jul 21
The company will recruit up to 40 patients with monomorphic VT of both ischemic and non-ischemic origin in…
05 Jul 21
The PIONEER IV clinical trial will recruit up to 2,540 patients suffering from any type of coronary heart…
02 Jul 21
FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart…
30 Jun 21
The DEFINE AFib study will use data collected from the LINQ family of insertable cardiac monitors